Skip to search formSkip to main contentSkip to account menu

odiparcil

Known as: 4-Methyl-7-(5-Thio-beta-D-Xylopyranosyloxy)-2H-Chromen-2-One 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Glycosides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Use of odiparcil for the treatment of mucopolysaccharidosis
2014
2014
Use of odiparcil to behandilng of mucopolysaccharidosis
2013
2013
Using the odiparcil in treating mucopolysaccharidosis
Review
2006
Review
2006
Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.
Current anticoagulant provision is dominated by parenteral heparin and oral warfarin, which act by inhibiting several steps of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)